Search Results - Andreas Pinter

Refine Results
  1. 1

    Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials by Andreas Pinter, Jordi Galván, Frank Freischläger

    Published in Dermatology and Therapy (2025-04-01)
    Get full text
    Article


  2. 2

    Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis by Andreas Pinter, Athanasios Tsianakas, Adina Eichner, for the ScaTAC study group

    Published in Dermatology and Therapy (2024-02-01)
    Get full text
    Article


  3. 3

    Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey by Andreas Pinter, Nicole Mielke, Bartosz Malisiewicz, Roland Kaufmann, Anke König

    Published in Dermatology and Therapy (2020-05-01)
    Get full text
    Article


  4. 4

    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin Accord... by Michael J. Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, Randy Prescilla

    Published in Acta Dermato-Venereologica (2024-02-01)
    Get full text
    Article


  5. 5

    Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PR... by Andreas Pinter, Jose Luis López Estebaranz, Anthony Bewley, Jordi Galván, Siva Narayanan, Volker Koscielny, Ismail Kasujee

    Published in JEADV Clinical Practice (2025-09-01)
    Get full text
    Article


  6. 6

    Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study by Andreas Pinter, Ahmed M. Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Bang Truong, Luis Puig, Mark Lebwohl

    Published in Dermatology and Therapy (2024-05-01)
    Get full text
    Article


  7. 7

    Influenza Vaccination in Psoriatic Patients—Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso) by Christian Kromer, Phoebe Wellmann, Ralf Siemer, Selina Klein, Johannes Mohr, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner

    Published in Vaccines (2021-08-01)
    Get full text
    Article


  8. 8

    Treatment switching and associated economic outcomes in patients with plaque psoriasis treated with biologics: A retrospective analysis of German claims data 2016−2021 by Andreas Pinter, Ahmed M. Soliman, Karina C. Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G. Lebwohl

    Published in JEADV Clinical Practice (2024-12-01)
    Get full text
    Article


  9. 9

    Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A S... by Linda Stein Gold, Andreas Pinter, April Armstrong, Matthias Augustin, Petr Arenberger, Neil Bhatia, Morten Praestegaard, Lars Iversen, Adam Reich

    Published in Dermatology and Therapy (2023-07-01)
    Get full text
    Article


  10. 10

    Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso by Phoebe Wellmann, Christian Kromer, Ralf Siemer, Selina Klein, Johannes Mohr, Undine Lippert, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner

    Published in Vaccines (2022-06-01)
    Get full text
    Article


  11. 11

    Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan by Yayoi Tada, Ahmed M. Soliman, Kanako Ishii, Ryuta Sakuma, Luis Puig, Matthew Davis, Dominic Nunag, Andreas Pinter, Shinichi Imafuku

    Published in Dermatology and Therapy (2023-11-01)
    Get full text
    Article


  12. 12

    Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data by Andreas Pinter, Ahmed M. Soliman, Karina C. Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G. Lebwohl

    Published in Dermatology and Therapy (2024-05-01)
    Get full text
    Article


  13. 13

    Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review by Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter

    Published in Dermatology and Therapy (2023-09-01)
    Get full text
    Article


  14. 14

    Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of hea... by Andreas Pinter, Kilian Eyerich, Antonio Costanzo, Alyssa Garrelts, Christopher Schuster, Can Mert, Anastasia Lampropoulou, Konstantinos Fotiou, Julia-Tatjana Maul, Kim A. Papp

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  15. 15

    Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research by Marina Otten, Matthias Augustin, Christine Blome, Janine Topp, Marina Niklaus, Caroline Hilbring, Falk G. Bechara, Andreas Pinter, Christos C. Zouboulis, Florian Anzengruber, Natalia Kirsten

    Published in Acta Dermato-Venereologica (2023-01-01)
    Get full text
    Article


  16. 16

    IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants... by Kristian Reich, Kilian Eyerich, Knut Schäkel, Peter Weisenseel, Andreas Pinter, Khusru Asadullah, Sven Wegner, Ernesto J Muñoz-Elias, Holger Bartz, Friedmann J H Taut

    Published in BMJ Open (2021-09-01)
    Get full text
    Article


  17. 17

    Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis by Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl, Andreas Pinter, Richard B. Warren, Luis Puig, Rhys Warham, Jérémy Lambert, Susanne Wiegratz, Balint Szilagyi, Andrew Blauvelt

    Published in Dermatology and Therapy (2024-09-01)
    Get full text
    Article


  18. 18

    Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with B... by Elisabeth Riedl, Andreas Pinter, Shirin Zaheri, Antonio Costanzo, Alan Brnabic, Bruce Konicek, Robert McKenzie, Anastasia Lampropoulou, Mohamed El Rayes, Natalie Haustrup, Christopher Schuster

    Published in Dermatology and Therapy (2024-04-01)
    Get full text
    Article


  19. 19

    Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Stud... by Andreas Pinter, Alan Brnabic, Emanuele Trovato, Lluís Puig, Jose-Manuel Carrascosa, Thierry Boyé, Matteo Megna, Silvia Sabatino, Inmaculada De La Torre, Julia-Tatjana Maul

    Published in Dermatology and Therapy (2025-07-01)
    Get full text
    Article


  20. 20

    High content imaging shows distinct macrophage and dendritic cell phenotypes for psoriasis and atopic dermatitis by Nathalie J. Behr, Sandra Pierre, Tanja Ickelsheimer, Nicole Ziegler, Sonja Luckhardt, Aimo Kannt, Andreas Pinter, Gerd Geisslinger, Stephan M. G. Schäfer, Anke König, Klaus Scholich

    Published in Scientific Reports (2025-05-01)
    Get full text
    Article


Search Tools: